Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

G0400007

Glycerol mono-oleate

European Pharmacopoeia (EP) Reference Standard

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C21H40O4
Numero CAS:
25496-72-4
Peso molecolare:
356.54
Codice UNSPSC:
41116107
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

glyceryl monooleate

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

InChI

1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h9-10,20,22-23H,2-8,11-19H2,1H3/b10-9-
RZRNAYUHWVFMIP-KTKRTIGZSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Glycerol mono-oleate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Ci dispiace, ma al momento non ci sono COA disponibili online per questo prodotto.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 6

1 of 6

1-Stearoyl-rac-glycerol ≥99%

Sigma-Aldrich

M2015

1-Stearoyl-rac-glycerol

1-Linoleoyl-rac-glycerol ≥97%, liquid

Sigma-Aldrich

M7640

1-Linoleoyl-rac-glycerol

1,3-Diolein ≥99% (GC)

Sigma-Aldrich

D3627

1,3-Diolein

2-Stearoylglycerol analytical standard

Supelco

36484

2-Stearoylglycerol

1,2-Dioleoyl-rac-glycerol ≥97%

Sigma-Aldrich

D8394

1,2-Dioleoyl-rac-glycerol

2-Palmitoylglycerol analytical standard

Supelco

75614

2-Palmitoylglycerol

Josephine Y T Chong et al.
Langmuir : the ACS journal of surfaces and colloids, 28(25), 9223-9232 (2012-05-29)
High-throughput methodologies have been employed to establish structure-property relationships and assess the effectiveness of nonionic steric stabilizers for inverse bicontinuous cubic lyotropic liquid crystalline nanoparticulate dispersions of monoolein and phytantriol. The ability of the stabilizers to disperse the lipids was
Chandrashekhar V Kulkarni
Nanoscale, 4(19), 5779-5791 (2012-08-18)
Lipid crystallization is ubiquitous in nature, observed in biological structures as well as in commercial products and applications. In a dehydrated state most of the lipids form well ordered crystals, whereas in an aqueous environment they self-assemble into various crystalline
Adam M Squires et al.
Langmuir : the ACS journal of surfaces and colloids, 29(6), 1726-1731 (2013-01-26)
We demonstrate a method by which we can produce an oriented film of an inverse bicontinuous cubic phase (Q(II)(D)) formed by the lipid monoolein (MO). By starting with the lipid as a disordered precursor (the L(3) phase) in the presence
Victoria M Steffes et al.
Biomaterials, 145, 242-255 (2017-09-11)
Lipid-based particles are used worldwide in clinical trials as carriers of hydrophobic paclitaxel (PTXL) for cancer chemotherapy, albeit with little improvement over the standard-of-care. Improving efficacy requires an understanding of intramembrane interactions between PTXL and lipids to enhance PTXL solubilization
Jaclyn M Hosmer et al.
Pharmaceutical research, 30(3), 694-706 (2012-11-09)
To develop liquid crystalline phases with monoglycerides, and assess whether the monoglyceride type favors cutaneous over transdermal paclitaxel delivery. BRIJ-based lamellar phases were prepared with 0.5% paclitaxel and 20% of either monocaprylin (LP-MC), monomyristolein (LP-MM) or monoolein (LP-MO). Skin electrical
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.